EB
PVLA

Eastern Bank’s Palvella Therapeutics PVLA Stock Holding History

Eastern Bank’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.95K Buy
+52
New +$6.31K ﹤0.01% 884

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Eastern Bank's PVLA Position: Q2 2026 in Review

Eastern Bank opened a new position in Palvella Therapeutics (PVLA) in Q2 2026: 52 shares worth $7.95K. The stake represents ﹤0.01% of the portfolio and ranks #884 among its holdings.

197 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Eastern Bank held 52 shares of Palvella Therapeutics worth $7.95K as of Q2 2026.
  • Palvella Therapeutics was a new Eastern Bank position in Q2 2026.
  • Palvella Therapeutics made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #884 holding.
  • 197 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.